Quantitative Testing of Healthcare Provider Knowledge about YESCARTA® (axicabtagene ciloleucel) Risk Minimisation Measures

25/03/2019
22/02/2024
EU PAS number:
EUPAS28523
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

KT-EU-471-0116-appendix-16.1.1-protocol_f-redact

English (1.24 MB - PDF) View document
Updated protocol

KT-EU-471-0116-appendix-16.1.1-protocol amendment 2_f-redact

First published: 22/02/2024
English (917.82 KB - PDF) View document
Study results
Study results

KT-EU-471-0116-csr-body final_f-redact

English (1.09 MB - PDF) View document
Study report
Other information